BridgeBio Oncology Therapeutics Inc (NAS:BBOT)
$ 9.33 +0.55 (+6.26%) Market Cap: 747.40 Mil Enterprise Value: 497.77 Mil PE Ratio: 0 PB Ratio: 2.01 GF Score: 12/100

BridgeBio Oncology Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 16, 2026 / 08:00PM GMT
Release Date Price: $7.73
Operator

Hello and welcome to the 2026 Virtual Annual Meeting of BridgeBio Oncology Therapeutics, Inc. Please note that today's meeting is being recorded. Stockholders may submit questions by following the instructions on the annual meeting interface.

Pedro Beltran
BridgeBio Oncology Therapeutics Inc - President, Chief Executive Officer, Director

Good morning, everyone. My name is Pedro J. Beltran, President and Chief Executive Officer of BridgeBio Oncology Therapeutics (technical difficulty) to record the minutes. It is a pleasure to welcome our shareholders to the annual meeting of the corporation. This meeting is being held in accordance with the corporation's bylaws and Delaware law. We will take care of the formal business at hand, which is described in our notice and proxy statement, a copy of which was mailed on or about April 28, 2026, to all of our stockholders of record at the close of business on April 20, 2026. All discussion will be limited to the official business at hand.

Before proceeding to the formal business, I would like to recognize the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot